How can pharmaceutical corporations successfully collaborate with tech startups?

01/17/2022 By Andrea

Article contributed by: Tristan Salomon, founder and CEO of Axom, and expert in Machine Learning, Big Data and AI. Any business needs to possess top-level technological advances not just to stand out from, but at least to keep up with the competition. This is especially true for pharmaceutical companies. The current pandemic situation has tested them […]

Pharma Leadership: Cultivating Talent in Uncertain Times

11/08/2021 By Andrea

Article contributed to PharmaLeaders and authored by: Beth Doladee, M.A., M.B.A., Managing Consultant and Neelima Paranjpey, Ph.D., Managing Consultant, The Vaya Group Executive Summary Today’s highly dynamic, fast-paced pharmaceutical industry requires knowledge preservation and leaders who understand these unique challenges. This means developing leadership from within, to preserve intellectual capital and ensure the right skills […]

Prellis, Bristol Myers Squibb collaborate to discover antibodies

01/21/2022

As part of the collaboration, the companies will use Prellis Biologics’ externalised human immune system (EXIS) which is based on human lymph node organoids (LNO). The human antibody The post Prellis, Bristol Myers Squibb collaborate to discover antibodies appeared first on Pharmaceutical Business … [Read More...]

Senhwa Biosciences receives ODD for Silmitasertib from FDA to treat biliary tract cancer

01/21/2022

Senhwa Biosciences acting CEO Mei-Hui Kuo said: “We are pleased to receive ODD for Silmitasertib for the treatment of Biliary Tract Cancer, a rare, malignant disease for which The post Senhwa Biosciences receives ODD for Silmitasertib from FDA to treat biliary tract cancer appeared first on … [Read More...]

Lantern Pharma and NCI expand oncology partnership

01/20/2022

The latest move follows the identification of various gene signatures that predict a tumour’s possible response to these drug candidates of Lantern. LP-184 is being analysed as a The post Lantern Pharma and NCI expand oncology partnership appeared first on Pharmaceutical Business review. … [Read More...]

Regeneron announces FDA acceptance for sBLA review of Libtayo with chemotherapy for NSCLC

01/20/2022

The date for the FDA decision is on 19 September 2022. The sBLA is backed by results from a randomized, multicenter Phase 3 study. The study investigated Libtayo The post Regeneron announces FDA acceptance for sBLA review of Libtayo with chemotherapy for NSCLC appeared first on Pharmaceutical … [Read More...]

Featured Article

How can pharmaceutical corporations successfully collaborate with tech startups?

Pharma Leadership: Cultivating Talent in Uncertain Times

White Papers

Healthcare Marketing Trends for 2019 Emphasize Better Targeting with Cost-Effective Advantages

7 Things You Must Know When Selecting an Electronic Lab Notebook

Industry News

Prellis, Bristol Myers Squibb collaborate to discover antibodies

Senhwa Biosciences receives ODD for Silmitasertib from FDA to treat biliary tract cancer

Lantern Pharma and NCI expand oncology partnership

Regeneron announces FDA acceptance for sBLA review of Libtayo with chemotherapy for NSCLC